News and Press Releases
Press releases
Theralase Discovers Anti-Cancer Drug Fluoresces in Tissue
Toronto, Ontario – May 14, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF: OTC Pink®), a leading bio...
0Theralase Manufactures High Purity Anti-Cancer Drug
Toronto, Ontario – May 12, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF: OTC Pink®), a leading bio...
0Theralase Increases Revenue 15% in 2014 Financials
Toronto, Ontario – May 1, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT: TSXV) (TLTFF: OTC Pink®) released its 2...
0Theralase Manufactures First Pre-Commercial Batch of Lead Anti-Cancer Drug
Toronto, Ontario – April 9, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF: OTC Pink®) announced tod...
0Theralase Holds pre-CTA Meeting with Health Canada
Toronto, Ontario – April 2, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF: OTC Pink®) announced tod...
0Theralase Partners with CiToxLAB for Toxicology
Toronto, Ontario – March 23, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF: OTC Pink®) announced to...
0Theralase Confirms Strategic Initiatives
Toronto, Ontario – March 11, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF: OTC Pink®) announced to...
0Theralase Announces Completion of Public Offering of Units
Toronto, Ontario – March 3, 2015, Theralase Technologies Inc. (“Theralase” or the “Corporation”) (TSXV:TLT) (OTC Pink®: TLTFF) is please...
0Theralase Identifies Potential Mechanism of How Lead Anti-Cancer Drug Works to Destroy Cancer and Discovers New Application to Detect Cancer Cells
Toronto, Ontario – February 23, 2015, Theralase Technologies Inc. (“Theralase”) (TLT:TSXV) (TLTFF: OTC Pink®) announced today that it has id...
0Theralase’s Lead Anti-Cancer Drug Has Significantly Less Skin Toxicity than FDA Approved Drug
Toronto, Ontario – February 13, 2015, Theralase Technologies Inc. (“Theralase”) (TLT:TSXV) (TLTFF: OTC Pink®), a developer of advanced Photo...
0in the news
BTv – Theralase® an innovative medical technology for bladder cancer treatment – 2018
Let's Stay in Touch
Sign up to our newsletter to stay informed on news and updates from Theralase Technologies Inc.
